TY - JOUR
T1 - Axl Mediates ZIKA Virus Entry in Human Glial Cells and Modulates Innate Immune Responses
AU - Meertens, Laurent
AU - Labeau, Athena
AU - Dejarnac, Ophelie
AU - Cipriani, Sara
AU - Sinigaglia, Laura
AU - Bonnet-Madin, Lucie
AU - Le Charpentier, Tifenn
AU - Hafirassou, Mohamed Lamine
AU - Zamborlini, Alessia
AU - Cao-Lormeau, Van-Mai
AU - Coulpier, Muriel
AU - Missé, Dorothée
AU - Jouvenet, Nolwenn
AU - Tabibiazar, Ray
AU - Gressens, Pierre
AU - Schwartz, Olivier
AU - Amara, Ali
N1 - Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.
PY - 2017/1/10
Y1 - 2017/1/10
N2 - ZIKA virus (ZIKV) is an emerging pathogen responsible for neurological disorders and congenital microcephaly. However, the molecular basis for ZIKV neurotropism remains poorly understood. Here, we show that Axl is expressed in human microglia and astrocytes in the developing brain and that it mediates ZIKV infection of glial cells. Axl-mediated ZIKV entry requires the Axl ligand Gas6, which bridges ZIKV particles to glial cells. Following binding, ZIKV is internalized through clathrin-mediated endocytosis and traffics to Rab5+ endosomes to establish productive infection. During entry, the ZIKV/Gas6 complex activates Axl kinase activity, which downmodulates interferon signaling and facilitates infection. ZIKV infection of human glial cells is inhibited by MYD1, an engineered Axl decoy receptor, and by the Axl kinase inhibitor R428. Our results highlight the dual role of Axl during ZIKV infection of glial cells: promoting viral entry and modulating innate immune responses. Therefore, inhibiting Axl function may represent a potential target for future antiviral therapies.
AB - ZIKA virus (ZIKV) is an emerging pathogen responsible for neurological disorders and congenital microcephaly. However, the molecular basis for ZIKV neurotropism remains poorly understood. Here, we show that Axl is expressed in human microglia and astrocytes in the developing brain and that it mediates ZIKV infection of glial cells. Axl-mediated ZIKV entry requires the Axl ligand Gas6, which bridges ZIKV particles to glial cells. Following binding, ZIKV is internalized through clathrin-mediated endocytosis and traffics to Rab5+ endosomes to establish productive infection. During entry, the ZIKV/Gas6 complex activates Axl kinase activity, which downmodulates interferon signaling and facilitates infection. ZIKV infection of human glial cells is inhibited by MYD1, an engineered Axl decoy receptor, and by the Axl kinase inhibitor R428. Our results highlight the dual role of Axl during ZIKV infection of glial cells: promoting viral entry and modulating innate immune responses. Therefore, inhibiting Axl function may represent a potential target for future antiviral therapies.
U2 - 10.1016/j.celrep.2016.12.045
DO - 10.1016/j.celrep.2016.12.045
M3 - Article
C2 - 28076778
SN - 2211-1247
VL - 18
SP - 324
EP - 333
JO - Cell Reports
JF - Cell Reports
IS - 2
ER -